The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Diagnostic validity of schizophreniform disorder

Published Online:https://doi.org/10.1176/ajp.151.6.815

OBJECTIVE: The author examined the validity of schizophreniform disorder as defined in DSM-III and DSM-III-R by critically reviewing the current literature. METHOD: Thirty publications that met specific inclusion criteria were identified and reviewed. To organize information relevant to the question of validity, the data were divided into three general classes of validators: antecedent, concurrent, and predictive. When possible, meta-analyses of specific validators were performed according to the summary odds ratio method of Mantel- Haenszel. RESULTS: The findings of this review failed to provide support for the validity of schizophreniform disorder, as it is currently defined, as a distinct diagnostic entity. In addition, the review did not provide strong support for schizophreniform disorder as representing a subtype of schizophrenia or affective illness. Instead, the data suggest that the current diagnostic criteria for schizophreniform disorder identify a heterogeneous group of patients with new-onset schizophrenia, schizoaffective disorder, and atypical affective disorder and a small subgroup with a remitting nonaffective psychosis. CONCLUSIONS: This review suggests that the diagnosis of schizophreniform disorder has limited clinical utility. Patients meeting criteria for schizophreniform disorder should instead be diagnosed as having psychotic disorder not otherwise specified until additional clinical information (e.g., course of illness) becomes available. Future research will require prospective longitudinal follow- up of patients with new-onset affective and nonaffective psychoses to identify the subgroup with "true" schizophreniform disorder, i.e., a remitting nonaffective psychosis.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.